Q-omics provides the consensus-scored ETDC profile across patient tissues and cancer cell-line models. Additionally, ETDC RNA expression shows 7,660 significant protein co-abundance associations, with the highest sampling consensus in LUAD.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for ETDC — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with ETDC in patient tissues and cancer cell lines. In patient samples, ETDC shows the broadest associations at the RNA and protein expression levels, with LUAD recurring as the lineage with the largest associated feature set. In cancer cell lines, ETDC RNA and mutation anchors are most strongly linked to RNA-expression features, especially in UPPER_AERODIGESTIVE_TRACT, while CRISPR and shRNA rows add functional-dependency signals in BLOOD_Lymphoma.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	7,660	LUAD (1592)	view →
Function (mass-spec)	563	CCRCC (122)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	365	UPPER_AERODIGESTIVE_TRACT (269)	view →
Mutation	113	BLOOD_Lymphoma (51)	view →